Hussain Herbal Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 33 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.01%
- Profit Growth 309.11%
- Ebitda -2.89%
- Net Worth 0.18%
- Total Assets -0.91%
About Hussain Herbal
Hussain Herbal Limited (HHL) is a Public Limited Indian Non-Government Company incorporated in India on 05 September 1991 and has a history of 33 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shahnaz Husain, Alok Choudhary, and Nelofar Currimbhoy serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231DL1991PLC045567
-
Company No.
045567
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
05 Sep 1991
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Hussain Herbal?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shahnaz Husain
|
Director | 05-Sep-1991 | Current |
|
Alok Choudhary
|
Director | 26-Apr-2005 | Current |
|
Nelofar Currimbhoy
|
Director | 02-Feb-2009 | Current |
Financial Performance of Hussain Herbal.
Hussain Herbal Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.01% increase. The company also saw a substantial improvement in profitability, with a 309.11% increase in profit. The company's net worth moved up by a moderate rise of 0.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hussain Herbal?
In 2023, Hussain Herbal had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shahnaz Ayurveda Private LimitedShahnaz Husain and Alok Choudhary are mutual person
-
A F F Flavours Pvt LtdShahnaz Husain and Alok Choudhary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hussain Herbal?
Hussain Herbal has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hussain Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hussain Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
